Literature DB >> 16194900

Bronchiolitis obliterans organizing pneumonia in a patient with non-Hodgkin's lymphoma following R-CHOP and pegylated filgrastim.

C Macartney1, E Burke, S Elborn, N Magee, P Noone, I Gleadhill, D Allen, P Kettle, M Drake.   

Abstract

Bronchiolitis obliterans organizing pneumonia (BOOP) presents with fever, dyspnoea, pleuritic chest pain and hypoxia. The diagnosis can be made from radiological appearances on chest radiograph and CT scan correlated with histological findings following biopsy. We present a 52-year-old gentleman undergoing treatment for high grade non-Hodgkin's lymphoma who developed respiratory symptoms during chemotherapy. BOOP was diagnosed and he responded well to oral prednisolone. The cause of BOOP is often not certain. However, in this case we suspect pegylated filgrastim or rituximab as possible agents.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16194900     DOI: 10.1080/10428190500144615

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  6 in total

1.  Respiratory distress and sudden death of a patient with GSDIb chronic neutropenia: possible role of pegfilgrastim.

Authors:  Jean Donadieu; Blandine Beaupain; Frédérique Rety-Jacob; Raphaelle Nove-Josserand
Journal:  Haematologica       Date:  2009-08       Impact factor: 9.941

2.  Fatal interstitial pneumonitis in a patient with relapsed diffuse large B cell lymphoma following yttrium-90 ibritumomab tiuxetan.

Authors:  Moon Jin Kim; Gyeong-Won Lee; Jong Woo Seo; Hyun-Jung Kim; Sung-Nam Lim; Cheolwon Suh
Journal:  Invest New Drugs       Date:  2010-05-21       Impact factor: 3.850

3.  A case of organizing pneumonia associated with rituximab.

Authors:  Chi Hoon Maeng; Sang Ouk Chin; Byung Hyuk Yang; Si-young Kim; Hwi-Joong Youn; Kyung Sam Cho; Sun Kyung Baek; Sun Lee
Journal:  Cancer Res Treat       Date:  2007-06-30       Impact factor: 4.679

Review 4.  Infiltrative lung diseases: complications of novel antineoplastic agents in patients with hematological malignancies.

Authors:  Bobbak Vahid; Paul E Marik
Journal:  Can Respir J       Date:  2008 May-Jun       Impact factor: 2.409

5.  Rituximab-induced bronchiolitis obliterans organizing pneumonia.

Authors:  Ahmet B Ergin; Nancy Fong; Hamed A Daw
Journal:  Case Rep Med       Date:  2012-06-19

Review 6.  Monoclonal antibody therapy and renal transplantation: focus on adverse effects.

Authors:  Gianluigi Zaza; Paola Tomei; Simona Granata; Luigino Boschiero; Antonio Lupo
Journal:  Toxins (Basel)       Date:  2014-02-28       Impact factor: 4.546

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.